Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01943045
What this trial is testing

Phase 2 Study of NGM282 in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
NGM Biopharmaceuticals, Inc 81
Early research (Phase 1)Study completedNCT01487811
What this trial is testing

Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 50
Early research (Phase 1)Study completedNCT03235219
What this trial is testing

A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 39
Testing effectiveness (Phase 2)Study completedNCT00576277
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain

Who this might be right for
Diabetic Neuropathy
Avigen 36
Large-scale testing (Phase 3)Study completedNCT00688701
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 361
Large-scale testing (Phase 3)Study completedNCT01113671
What this trial is testing

Type 2 Diabetes Haptoglobin Phenotype and Vitamin E

Who this might be right for
Diabetes Mellitus Type 2
Technion, Israel Institute of Technology 90
Early research (Phase 1)Ended earlyNCT00943371
What this trial is testing

A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 28
Large-scale testing (Phase 3)Study completedNCT00157586
What this trial is testing

Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)

Who this might be right for
Type 2 Diabetes
Mario Negri Institute for Pharmacological Research 342
Testing effectiveness (Phase 2)Study completedNCT05762471
What this trial is testing

Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObesityType2 Diabetes Mellitus
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07616206
What this trial is testing

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems

Who this might be right for
Type 1 Diabetes (T1D)
vTv Therapeutics 40
Early research (Phase 1)Study completedNCT01473953
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 31
Testing effectiveness (Phase 2)Study completedNCT01845064
What this trial is testing

Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients

Who this might be right for
Diabetes Type 2
DiaMedica Therapeutics Inc 98
Early research (Phase 1)Ended earlyNCT02686281
What this trial is testing

Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes

Who this might be right for
Healthy
Genmedica Therapeutics S.L. 19
Post-approval studies (Phase 4)Study completedNCT02653209
What this trial is testing

TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust 525
Large-scale testing (Phase 3)UnknownNCT01257334
What this trial is testing

Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea

Who this might be right for
Type 2 Diabetes
Taipei Medical University WanFang Hospital 1,390
Post-approval studies (Phase 4)UnknownNCT00427271
What this trial is testing

Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetes MellitusMicroalbuminuria
Hospital de Clinicas de Porto Alegre 20
Testing effectiveness (Phase 2)Study completedNCT00638716
What this trial is testing

Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
ConjuChem 122
Testing effectiveness (Phase 2)Study completedNCT00422487
What this trial is testing

Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Gilead Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT02053116
What this trial is testing

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 8
Post-approval studies (Phase 4)Study completedNCT01611883
What this trial is testing

The Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)

Who this might be right for
Hypercholesterolemia
Organon and Co 152
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation